Joint Formulary & PAD

Methylthioninium chloride - Methaemoglobinaemia

You are here : Home > Formulary Search > Methylthioninium chloride - Methaemoglobinaemia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous injection (IV)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Preferred

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Methylthioninium chloride
Indication :
Methaemoglobinaemia
Group Name :
Keywords :
Methylene blue
Brand Names Include :
Important Information :

Methylene Blue

https://www.toxbase.org/

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Methylthioninium chloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Methaemoglobinaemia.

  • No records returned.